Eugene_Sim.jpeg

Dr Eugene Sim

MBBS (S'pore), FRCS (Gen Surg) (Glasg), FRCS (Gen Surg) (Edin), FAMS (S'pore)



Cardiothoracic & Vascular surgeon
Senior Consultant
 

Dr Eugene Sim is an experiemced cardiothoracic surgeon. He has  performed more than 3000 cases of open heart surgery. 

Dr Sim received a Singapore Government Merit Scholarship to study Medicine and graduated from the National University of Singapore in 1984. He commenced his training in surgery and was admitted as a fellow of the Royal College of Surgeons of Edinburgh as well as a Fellow of the Royal College of Surgeons and Physicians of Glasgow in 1989.

Dr Sim’s subsequent cardiothoracic surgery training included two years in the United States with fellowships at the prestigious Mayo Clinic in Rochester, Minnesota, Texas Heart Institute in Houston, Texas and the Hospital for Sick Children in Toronto.

He has more than 150 scientific publications and 200 scientific presentations and is regularly invited to speak at regional and international cardiac surgical meetings. He is active in academic and research work.

In Nov 1995 he was one of the first surgeons in Asia to perform minimally invasive direct coronary artery bypass grafting and has performed more than 100 such procedures to date. He was also the first surgeon in Asia to perform off-pump coronary artery bypass grafting using the Octopus stabilizer and has conducted many training courses to train surgeons in the use of this new technique.

He was one of the first surgeons in the region to perform thoracoscopic ligation of a patent ductus arteriosus in Dec 1995, Thoracoscopic anterior release for scoliosis in January 1996, thoracoscopic thymectomy in 1997, multivessel off pump coronary artery bypass grafting in July 1997 and robotic assisted coronary artery bypass surgery in April 2000. Dr Sim was appointed to the Board of Directors of the International Society of Minimally Invasive Cardiac Surgery in 2001.

Dr Sim has conducted more than 10 approved trials on new surgical techniques and equipment. He is a director of two biotechnology companies and sit on many scientific advisory boards. He has also been consulted by and advised various international medical device companies.

Dr Sim is renowned for his work on cell and myoblast transplant for heart failure. His work has been presented at the Scientific sessions of the American Heart Association, The American College of Cardiology, The European Association of Cardiovascular and Thoracic Surgery and the European Congress of Cardiology. On 14 May 2002, he become the first surgeon in Asia to perform pure myoblast transplantation in the failing heart.

 

He was appointed as Head and Chief cardiothoracic surgery Gleneagles JPMC in Aug 2004 and Medical Director of Gleneagles JPMC in Feb 2005.